Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Effects of Tai Chi in Individuals With Multiple Sclerosis

9. november 2026 oppdatert av: Büşra ÇATALTAŞ, Pamukkale University

The Effects of Tai Chi on Executive Functions in Individuals With Multiple Sclerosis: A Randomized Controlled Trial

This study aimed to evaluate the effects of Tai Chi exercise on cognitive functions, fatigue, and depressive symptoms in individuals with Multiple Sclerosis (MS). MS is a chronic neurological disease characterized by demyelination within the central nervous system and is frequently associated with cognitive, physical, and psychological impairments.

Individuals diagnosed with MS were assigned to either an 8-week Tai Chi exercise program or a home-based Frenkel exercise program. Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R). Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The study aimed to investigate the effects of Tai Chi exercise compared with a home-based exercise program on cognitive performance, fatigue, and depressive symptoms in individuals with MS. The findings may contribute to the evidence base for non-pharmacological rehabilitation approaches in MS management.

Studieoversikt

Detaljert beskrivelse

Multiple Sclerosis (MS) is a chronic, immune-mediated neurological disease characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Cognitive impairment, fatigue, and depression are among the most common and disabling symptoms in individuals with MS, significantly affecting their quality of life. In addition to pharmacological treatments, exercise-based rehabilitation approaches have gained increasing attention in recent years.

This randomized controlled study investigated the effects of a structured Tai Chi exercise program on cognitive functions, fatigue, and depressive symptoms in individuals with MS. Participants diagnosed with MS were randomly allocated to either a Tai Chi intervention group or an active control group receiving a home-based Frenkel exercise program. Both groups continued their standard medical care throughout the study.

The Tai Chi intervention was conducted over 8 weeks, with two supervised sessions per week. Each session lasted approximately 50 minutes and included warm-up exercises, Tai Chi practice, and cool-down activities.

Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises three tests: the Symbol Digit Modalities Test (SDMT), assessing information processing speed; the California Verbal Learning Test-II (CVLT-II), assessing verbal learning and memory; and the Brief Visuospatial Memory Test-Revised (BVMT-R), assessing visuospatial learning and memory. Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The primary outcome was cognitive performance following the intervention, while secondary outcomes included changes in fatigue and depressive symptoms. All outcome measures were assessed at baseline and after the 8-week intervention period.

This study aimed to contribute to the evidence regarding the potential role of Tai Chi as a non-pharmacological rehabilitation approach for managing cognitive and psychological symptoms in individuals with MS.

Studietype

Intervensjonell

Registrering (Faktiske)

44

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Denizli
      • Denizli, Denizli, Tyrkia (Türkiye), 20000
        • Pamukkale University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

20 år til 60 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Diagnosis of multiple sclerosis (MS) according to the McDonald criteria.
  2. Relapsing-remitting multiple sclerosis (RRMS) phenotype.
  3. Age between 20 and 60 years.
  4. Willingness to participate in the study.
  5. Expanded Disability Status Scale (EDSS) score ≤3.5.

Exclusion Criteria:

  1. Use of medications that could affect clinical assessment or cognitive test performance, including antipsychotic medications or continuous corticosteroid or immunosuppressive therapy within the preceding month.
  2. Presence of additional neurological, psychiatric, or systemic diseases that could affect clinical or cognitive assessments.
  3. Participation in another structured exercise program.
  4. Experiencing an MS relapse within the preceding four weeks.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Tai Chi Intervention Group

Participants received an 8-week Tai Chi intervention program designed for individuals with Multiple Sclerosis. The program included coordinated body movements, breathing control, and mindful movement practice, aiming to improve cognitive function, reduce fatigue, and improve depression levels in individuals with MS. The program consisted of progressively taught 8 movements selected from the basic 10 Yang-style forms, focusing on controlled weight shifting, postural alignment, and whole-body coordination. Each session consisted of a warm-up phase with general stretching exercises, a main Tai Chi practice component with form repetition and rest breaks as needed, and a cool-down phase including stretching and controlled breathing exercises.

Tai Chi was administered for 8 weeks, 2 days per week, for a total of 16 sessions. Each session lasted approximately 50 minutes and included warm-up stretching exercises (10 minutes), Tai Chi practice (30 minutes), and cool-down exercises (10 minutes). Sessions were conducted in groups of 2-3 participants under physiotherapist supervision.

Aktiv komparator: Home Exercises Group

Participants in this group received an 8-week home exercise program consisting of Frenkel coordination exercises. They were instructed to perform the prescribed exercises independently at home throughout the study period. Participants did not participate in the Tai Chi intervention. The program served as an active comparator for evaluating the effects of Tai Chi on cognitive function, fatigue, and depression in individuals with MS.

Participants performed a home-based Frenkel exercise program for 8 weeks, twice weekly. Each session lasted approximately 15-30 minutes, excluding rest periods. Participants received an instructional booklet and an exercise logbook to record their exercise sessions. Adherence was monitored through telephone follow-up calls every two weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Cognitive functions assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
Tidsramme: Baseline and 8 weeks after the intervention

Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which includes the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R).

Baseline and 8 weeks after the intervention
Symbol Digit Modalities Test (SDMT)
Tidsramme: Baseline and 8 weeks after the intervention.

Information processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Higher scores indicate better cognitive performance

Baseline and 8 weeks after the intervention.
California Verbal Learning Test-II (CVLT-II)
Tidsramme: Baseline and 8 weeks after the intervention.

Verbal learning and memory were assessed using the California Verbal Learning Test-II (CVLT-II). Higher scores indicate better verbal learning and memory performance.

Baseline and 8 weeks after the intervention.
Brief Visuospatial Memory Test-Revised (BVMT-R)
Tidsramme: Baseline and 8 weeks after the intervention.

Visuospatial learning and memory were assessed using the Brief Visuospatial Memory Test-Revised (BVMT-R). Higher scores indicate better visuospatial learning and memory performance.

Baseline and 8 weeks after the intervention.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Fatigue Impact Scale (FIS) score
Tidsramme: Baseline and 8 weeks after the intervention

The impact of fatigue on physical, cognitive, and social functioning was assessed using the Fatigue Impact Scale (FIS). Lower scores indicate less fatigue-related impact.

Baseline and 8 weeks after the intervention
Beck Depression Inventory (BDI) score
Tidsramme: Baseline and 8 weeks after the intervention

Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Lower scores indicate fewer depressive symptoms.

Baseline and 8 weeks after the intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

2. oktober 2023

Primær fullføring (Faktiske)

28. februar 2025

Studiet fullført (Faktiske)

28. februar 2025

Datoer for studieregistrering

Først innsendt

4. november 2026

Først innsendt som oppfylte QC-kriteriene

4. november 2026

Først lagt ut (Faktiske)

10. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere